Landos Biopharma

YTD

ALL

Why Robinhood?

You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!

About LABP

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients. The listed name for LABP is Landos Biopharma, Inc.

CEO

Gregory Oakes, MBA

CEOGregory Oakes, MBA

Employees

—

Employees—

Headquarters

Roanoke, Virginia

HeadquartersRoanoke, Virginia

Founded

2017

Founded2017

Employees

—

Employees—

LABP Key Statistics

Market cap

10.57M

Market cap10.57M

Price-Earnings ratio

-5.74

Price-Earnings ratio-5.74

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$22.94

52 Week high$22.94

52 Week low

$21.90

52 Week low$21.90